JP2010500291A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500291A5
JP2010500291A5 JP2009523112A JP2009523112A JP2010500291A5 JP 2010500291 A5 JP2010500291 A5 JP 2010500291A5 JP 2009523112 A JP2009523112 A JP 2009523112A JP 2009523112 A JP2009523112 A JP 2009523112A JP 2010500291 A5 JP2010500291 A5 JP 2010500291A5
Authority
JP
Japan
Prior art keywords
antibody
csfr
csf
pharmaceutical composition
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009523112A
Other languages
English (en)
Japanese (ja)
Other versions
JP5235881B2 (ja
JP2010500291A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2007/001127 external-priority patent/WO2008017126A1/en
Publication of JP2010500291A publication Critical patent/JP2010500291A/ja
Publication of JP2010500291A5 publication Critical patent/JP2010500291A5/ja
Application granted granted Critical
Publication of JP5235881B2 publication Critical patent/JP5235881B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009523112A 2006-08-11 2007-08-10 肺疾患病態の処理 Expired - Fee Related JP5235881B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2006904378 2006-08-11
AU2006904378A AU2006904378A0 (en) 2006-08-11 Treatment and prophylaxis of pulmonary disease conditions
PCT/AU2007/001127 WO2008017126A1 (en) 2006-08-11 2007-08-10 Treatment of pulmonary disease conditions

Publications (3)

Publication Number Publication Date
JP2010500291A JP2010500291A (ja) 2010-01-07
JP2010500291A5 true JP2010500291A5 (cg-RX-API-DMAC7.html) 2010-09-24
JP5235881B2 JP5235881B2 (ja) 2013-07-10

Family

ID=39032559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523112A Expired - Fee Related JP5235881B2 (ja) 2006-08-11 2007-08-10 肺疾患病態の処理

Country Status (10)

Country Link
US (2) US8574572B2 (cg-RX-API-DMAC7.html)
EP (2) EP2526959B1 (cg-RX-API-DMAC7.html)
JP (1) JP5235881B2 (cg-RX-API-DMAC7.html)
AU (1) AU2007283463B2 (cg-RX-API-DMAC7.html)
CA (1) CA2661446C (cg-RX-API-DMAC7.html)
DK (1) DK2056858T3 (cg-RX-API-DMAC7.html)
ES (1) ES2506065T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ574285A (cg-RX-API-DMAC7.html)
PL (1) PL2056858T3 (cg-RX-API-DMAC7.html)
WO (1) WO2008017126A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012001306A (es) * 2009-07-31 2012-02-28 Genentech Inc Inhibicion de matastasis de tumor.
CN102630167B (zh) * 2009-09-15 2015-06-10 Csl有限公司 神经病的治疗
CA2795145C (en) * 2010-04-02 2019-01-22 Curna, Inc. Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
JP6187777B2 (ja) * 2011-06-13 2017-08-30 シーエスエル、リミテッド G−csfrに対する抗体およびその使用
CA2986097A1 (en) * 2015-05-18 2016-11-24 The University Of British Columbia Methods and systems of detecting plasma protein biomarkers for diagnosing acute exacerbation of copd
JP6944701B2 (ja) * 2016-10-21 2021-10-06 国立大学法人山口大学 CD11bアンタゴニストを含む劇症型急性肺炎治療用組成物
DK3717011T5 (da) * 2017-11-29 2024-08-26 Csl Ltd Fremgangsmåde til behandling eller forebyggelse af iskæmi-reperfusionsskade
WO2019178645A1 (en) 2018-03-23 2019-09-26 Csl Limited Method of treating asthma
US20220220209A1 (en) * 2018-12-04 2022-07-14 CSL Innovation Pty Ltd Method of treating neutrophilic conditions
AU2021285088A1 (en) * 2020-06-04 2023-01-05 CSL Innovation Pty Ltd Method of treating or preventing acute respiratory distress syndrome
WO2025007195A1 (en) 2023-07-05 2025-01-09 CSL Innovation Pty Ltd Methods of treating or preventing a complication of sickle cell disease

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4740461A (en) 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
GB2183662B (en) 1985-04-01 1989-01-25 Celltech Ltd Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4959455A (en) 1986-07-14 1990-09-25 Genetics Institute, Inc. Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4912040A (en) 1986-11-14 1990-03-27 Genetics Institute, Inc. Eucaryotic expression system
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5476996A (en) 1988-06-14 1995-12-19 Lidak Pharmaceuticals Human immune system in non-human animal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IE66494B1 (en) 1989-09-26 1996-01-10 Immunex Corp Granulocyte-colony stimulating factor receptors
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
ATE139258T1 (de) 1990-01-12 1996-06-15 Cell Genesys Inc Erzeugung xenogener antikörper
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
RO116404B1 (ro) 1991-07-25 2001-01-30 Idec Pharmaceuticals Corp San Anticorp recombinant, acid nucleic care il codifica, procedeu de obtinere a anticorpului recombinant si metoda de tratament cu acesta
WO1993011236A1 (en) 1991-12-02 1993-06-10 Medical Research Council Production of anti-self antibodies from antibody segment repertoires and displayed on phage
ES2230848T3 (es) 1998-04-28 2005-05-01 Smithkline Beecham Corporation Anticuerpos monoclonales con inmunogenicidad reducida.
CN1671416B (zh) 2001-07-12 2013-01-02 杰斐逊·富特 超人源化抗体
DE60329402D1 (de) * 2002-08-23 2009-11-05 Inst Medical W & E Hall Behandlungs- und prophylaxeverfahren
JP5036557B2 (ja) * 2005-01-13 2012-09-26 グラクソ グループ リミテッド 抗炎症活性デクラジノシル−マクロライド
WO2006077504A2 (en) 2005-01-18 2006-07-27 Koninklijke Philips Electronics N.V. An algorithm for growing 4-connected cores in image segmentation
US20090007281A1 (en) * 2006-01-13 2009-01-01 Battelle Memorial Institute Animal Model for Assessing Copd-Related Diseases

Similar Documents

Publication Publication Date Title
JP2010500291A5 (cg-RX-API-DMAC7.html)
JP2005530490A5 (cg-RX-API-DMAC7.html)
JP2011500003A5 (cg-RX-API-DMAC7.html)
JP2015519891A5 (cg-RX-API-DMAC7.html)
JP2016116520A5 (cg-RX-API-DMAC7.html)
JP2018126141A5 (cg-RX-API-DMAC7.html)
JP2007505627A5 (cg-RX-API-DMAC7.html)
JP2012505660A5 (cg-RX-API-DMAC7.html)
JP2014511686A5 (cg-RX-API-DMAC7.html)
JP2008546390A5 (cg-RX-API-DMAC7.html)
JP2010528601A5 (cg-RX-API-DMAC7.html)
JP2012505657A5 (cg-RX-API-DMAC7.html)
JP2011516410A5 (cg-RX-API-DMAC7.html)
JP2018510621A5 (cg-RX-API-DMAC7.html)
JP2020500929A5 (cg-RX-API-DMAC7.html)
JP2013504603A5 (cg-RX-API-DMAC7.html)
JP2012050438A5 (cg-RX-API-DMAC7.html)
JP2011518886A5 (cg-RX-API-DMAC7.html)
CN115515560B (zh) 冠状病毒感染的治疗
JP2015511625A5 (cg-RX-API-DMAC7.html)
JP2014504857A5 (cg-RX-API-DMAC7.html)
CA2558212A1 (en) Interferon-beta for anti-virus therapy for respiratory diseases
EP3317290A1 (en) Compositions and methods for the treatment of viral infection
JP2010540649A5 (cg-RX-API-DMAC7.html)
JP2019196384A5 (cg-RX-API-DMAC7.html)